Billable / Specific Code
ICD-10-CM C46.4 is the diagnosis code for Kaposi's sarcoma of gastrointestinal sites. This code falls under the section "Malignant neoplasms of mesothelial and soft tissue" within Chapter 2 — Neoplasms (C00-D49). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where C46.4 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, C46.4 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
C46.4 is the ICD-10-CM diagnosis code for "Kaposi's sarcoma of gastrointestinal sites". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of C46.4 is C46 ("Kaposi's sarcoma"). C46.4 provides a more specific classification within this category.
C46.4 is located in Section C45-C49 — "Malignant neoplasms of mesothelial and soft tissue" within Chapter 2 of the ICD-10-CM Tabular List.
Use C46.4 when the patients documented diagnosis matches "Kaposi's sarcoma of gastrointestinal sites" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Kaposi's sarcoma of gastrointestinal sites is C46.4.
Yes, C46.4 can be used as a primary diagnosis code since it is billable and specific.
C46.4 is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C46.4 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.